Compositions, methods, and systems for the synthesis and use of imaging agents
US-2025170282-A1 · May 29, 2025 · US
In vivo imaging method of mood disorders
US9168317B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9168317-B2 |
| Application number | US-201113825372-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 23, 2011 |
| Priority date | Jun 21, 2010 |
| Publication date | Oct 27, 2015 |
| Grant date | Oct 27, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a method useful in the diagnosis and/or monitoring of mood disorders wherein there is an abnormal expression of PBR. The method of the invention is useful in the differential diagnosis of said mood disorders and other conditions where there is no abnormal expression of PBR but where the symptoms may be similar to those of said mood disorder.
First claim
Opening claim text (preview).
What is claimed is: 1. A method comprising the following steps: (a) administering to a subject of a mood disorder characterised by abnormal expression of peripheral benzodiazepine receptors (PBR) an in vivo imaging agent of Formula I: wherein: R 1 is C 1-3 alkyl or C 1-3 fluoroalkyl; R 2 is hydrogen, hydroxyl, halo, cyano, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 flu…
Assignees
Inventors
Classifications
- A61K51/041Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K51/0446Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9168317B2 cover?
- The present invention provides a method useful in the diagnosis and/or monitoring of mood disorders wherein there is an abnormal expression of PBR. The method of the invention is useful in the differential diagnosis of said mood disorders and other conditions where there is no abnormal expression of PBR but where the symptoms may be similar to those of said mood disorder.
- Who is the assignee on this patent?
- Jones Paul Alexander, Ge Healthcare Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K51/041. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).